Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on June 27, 2007
JNCI Journal of the National Cancer Institute 2007 99(13):1051-1052; doi:10.1093/jnci/djm016
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/13/1051    most recent
djm016v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hershman, D.
Right arrow Articles by Grann, V.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hershman, D.
Right arrow Articles by Grann, V.
Related Collections
Right arrowRelated Correspondence
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press.

CORRESPONDENCE

Response: Re: Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy

Dawn Hershman, Alfred I. Neugut, Victor Grann

Affiliation of authors: Departments of Medicine (DH, AIN), Epidemiology (DH, AIN), and Medicine, Epidemiology, and Health Policy (VG), Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY

Correspondence to: Dawn Hershman, MD, MS, Department of Medical Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University, 161 Ft Washington Ave, Rm 1068, New York, NY 10032 (e-mail: dlh23@columbia.edu).

The first 10% of the full text of this article appears below.

We are grateful to the authors of the letters for the opportunity to clarify two issues that were addressed in the Discussion of our paper (1). The first issue, raised by Warren and Brown, addresses the quality and validity of the Surveillance, Epidemiology, and End Results (SEER)–Medicare database. We agree with the authors that our . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Correspondence

Re: Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy
Matteo Clavarezza, Lucia Del Mastro, Paolo Pronzato, Paolo Bruzzi, and Marco Venturini
J Natl Cancer Inst 2007 99: 1050-1051. [Extract] [Full Text] [PDF]

Re: Acute Myeloid Leukemia or Myelodysplastic Syndrome Following Use of Granulocyte Colony-Stimulating Factors During Breast Cancer Adjuvant Chemotherapy
Joan L. Warren and Martin L. Brown
J Natl Cancer Inst 2007 99: 1050. [Extract] [Full Text] [PDF]